Empowering Decisions in Today's Tough Pharma Market

As market pressures demand increased innovation and shorter time-to-market product lifecycles, pharmaceutical companies need to re-think evaluating alternative business models, focusing on technologies like business intelligence (BI) tools.

Pharmaceutical companies use Business Intelligence software to excel in an increasingly competitive market by improving product development, enhancing go-to-market strategies, and optimizing their supply chains.

BI enables pharmaceuticals companies to gain a complete view of the product development process to increase efficiency and optimise the cost/value relationship; monitor performance against key milestones such as vendor selection, site initiations, enrollment, drug shipments and availability; integrate plans and budgets to provide visibility into spending, predict clinical expenses and maximise financial capital leverage; aggregate customer, channel and product data for a single view of sales volume and to drive more targeted deployment; enable driver-based planning to make better decisions about resource allocations such as marketing programmes, advertising and samples; and improve contracting effectiveness through better planning and analysis of key performance indicators, historical performance and scenario analysis.